DRUG Institutional Ownership & Shareholders
BRIGHT MINDS BIOSCIENCES INC (DRUG) is currently held by 103 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $651.60M based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Janus Henderson Group Plc is currently the largest disclosed institutional shareholder of DRUG tracked by InsiderSet, reporting ownership valued at approximately $93.52M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $70.61M, representing an estimated loss of -24.49% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 64% of the total disclosed DRUG value among the investors covered in this analysis. Major shareholders include Janus Henderson Group Plc, Cormorant Asset Management, Lp, Blackrock, Inc., and several other long-term asset managers with concentrated positions in BRIGHT MINDS BIOSCIENCES INC (DRUG).
This page ranks the largest institutional DRUG shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
103
Total Reported Value
$651.60M
Largest Holder
Janus Henderson Group Plc
Largest Position
$93.52M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
121
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Janus Henderson Group Plc | 0.05% | 1,284,324 | $93,518,052 | $70,612,134 | -$22,905,918 | -24.49% | |
| Cormorant Asset Management, Lp | 3.24% | 900,000 | $63,180,000 | $49,482,000 | -$13,698,000 | -21.68% | |
| Blackrock, Inc. | 0.00% | 686,184 | $48,170,117 | $37,726,396 | -$10,443,721 | -21.68% | |
| Vivo Capital, Llc | 3.57% | 557,172 | $39,113,474 | $30,633,317 | -$8,480,157 | -21.68% | |
| Vestal Point Capital, Lp | 0.89% | 545,000 | $38,259,000 | $29,964,100 | -$8,294,900 | -21.68% | |
| Braidwell Lp | 1.26% | 483,822 | $33,964,304 | $26,600,534 | -$7,363,770 | -21.68% | |
| Driehaus Capital Management Llc | 0.18% | 433,377 | $30,423,065 | $23,827,067 | -$6,595,998 | -21.68% | |
| Balyasny Asset Management L.P. | 0.04% | 345,053 | $24,222,721 | $18,971,014 | -$5,251,707 | -21.68% | |
| Adage Capital Partners Gp, L.L.C. | 0.03% | 335,000 | $23,517,000 | $18,418,300 | -$5,098,700 | -21.68% | |
| Point72 Asset Management, L.P. | 0.04% | 327,416 | $22,984,603 | $18,001,332 | -$4,983,271 | -21.68% | |
| Deerfield Management Company, L.P. | 0.21% | 283,000 | $19,866,600 | $15,559,340 | -$4,307,260 | -21.68% | |
| Ra Capital Management, L.P. | 0.16% | 265,000 | $18,603,000 | $14,569,700 | -$4,033,300 | -21.68% | |
| Parkman Healthcare Partners Llc | 1.48% | 205,053 | $14,394,721 | $11,273,814 | -$3,120,907 | -21.68% | |
| Mpm Bioimpact Llc | 0.87% | 202,114 | $14,188,403 | $11,112,228 | -$3,076,175 | -21.68% | |
| Wellington Management Group Llp | 0.00% | 171,315 | $12,026,312 | $9,418,899 | -$2,607,413 | -21.68% | |
| Goldman Sachs Group Inc | 0.00% | 133,689 | $9,384,968 | $7,350,221 | -$2,034,747 | -21.68% | |
| Eventide Asset Management, Llc | 0.12% | 130,013 | $9,126,913 | $7,148,115 | -$1,978,798 | -21.68% | |
| State Street Corp | 0.00% | 122,178 | $8,576,896 | $6,717,346 | -$1,859,550 | -21.68% | |
| Seven Grand Managers, Llc | 0.34% | 120,000 | $8,424,000 | $6,597,600 | -$1,826,400 | -21.68% | |
| Great Point Partners Llc | 1.81% | 109,603 | $7,694,131 | $6,025,973 | -$1,668,158 | -21.68% | |
| Geode Capital Management, Llc | 0.00% | 104,146 | $7,311,049 | $5,725,947 | -$1,585,102 | -21.68% | |
| Orbimed Advisors Llc | 0.12% | 93,000 | $6,528,600 | $5,113,140 | -$1,415,460 | -21.68% | |
| Acuta Capital Partners, Llc | 4.54% | 92,745 | $6,510,699 | $5,099,120 | -$1,411,579 | -21.68% | |
| Ikarian Capital, Llc | 1.02% | 88,951 | $6,244,361 | $4,890,526 | -$1,353,835 | -21.68% | |
| Vanguard Portfolio Management Llc | 0.00% | 80,060 | $5,620,212 | $4,401,699 | -$1,218,513 | -21.68% | |
| Sio Capital Management, Llc | 0.89% | 73,952 | $5,191,430 | $4,065,881 | -$1,125,549 | -21.68% | |
| Trexquant Investment Lp | 0.03% | 70,615 | $4,957,173 | $3,882,413 | -$1,074,760 | -21.68% | |
| B Group, Inc. | 2.69% | 67,500 | $4,738,500 | $3,711,150 | -$1,027,350 | -21.68% | |
| Millennium Management Llc | 0.00% | 66,740 | $4,685,148 | $3,669,365 | -$1,015,783 | -21.68% | |
| Citadel Advisors Llc | 0.00% | 66,533 | $4,670,616 | $3,657,984 | -$1,012,632 | -21.68% | |
| Schonfeld Strategic Advisors Llc | 0.02% | 66,277 | $4,652,645 | $3,643,909 | -$1,008,736 | -21.68% | |
| Walleye Capital Llc | 0.02% | 66,106 | $4,640,641 | $3,634,508 | -$1,006,133 | -21.68% | |
| Woodline Partners Lp | 0.01% | 45,668 | $3,205,894 | $2,510,827 | -$695,067 | -21.68% | |
| Northern Trust Corp | 0.00% | 42,466 | $2,981,114 | $2,334,781 | -$646,333 | -21.68% | |
| Artia Global Partners Lp | 0.51% | 38,407 | $2,696,171 | $2,111,617 | -$584,554 | -21.68% | |
| Ameriprise Financial Inc | 0.00% | 37,902 | $2,660,720 | $2,083,852 | -$576,868 | -21.68% | |
| Los Angeles Capital Management Llc | 0.01% | 35,747 | $2,509,440 | $1,965,370 | -$544,070 | -21.68% | |
| Kvp Capital Advisors, Lp | 1.64% | 31,813 | $2,233,273 | $1,749,079 | -$484,194 | -21.68% | |
| Superstring Capital Management Lp | 1.35% | 30,456 | $2,138,011 | $1,674,471 | -$463,540 | -21.68% | |
| Adar1 Capital Management, Llc | 0.10% | 30,300 | $2,127,060 | $1,665,894 | -$461,166 | -21.68% | |
| Boothbay Fund Management, Llc | 0.04% | 27,870 | $1,956,474 | $1,532,293 | -$424,181 | -21.68% | |
| Bank Of America Corp | 0.00% | 26,966 | $1,893,013 | $1,482,591 | -$410,422 | -21.68% | |
| Advisorshares Investments Llc | 0.21% | 24,274 | $1,704,035 | $1,334,585 | -$369,450 | -21.68% | |
| Aquatic Capital Management Llc | 0.05% | 20,831 | $1,462,336 | $1,145,288 | -$317,048 | -21.68% | |
| Platinum Investment Management Ltd | 0.33% | 19,127 | $1,342,715 | $1,051,602 | -$291,113 | -21.68% | |
| Morgan Stanley | 0.00% | 18,599 | $1,305,698 | $1,022,573 | -$283,125 | -21.68% | |
| Charles Schwab Investment Management Inc | 0.00% | 18,032 | $1,265,846 | $991,399 | -$274,447 | -21.68% | |
| Nuveen, Llc | 0.00% | 16,889 | $1,185,608 | $928,557 | -$257,051 | -21.68% | |
| Ubs Group Ag | 0.00% | 15,536 | $1,090,627 | $854,169 | -$236,458 | -21.68% | |
| Bank Of New York Mellon Corp | 0.00% | 14,902 | $1,046,100 | $819,312 | -$226,788 | -21.68% |
Frequently asked questions about DRUG
Who are the largest institutional holders of DRUG?
The largest institutional holders of DRUG reported in the latest SEC Form 13F filings include Janus Henderson Group Plc, Cormorant Asset Management, Lp, Blackrock, Inc., Vivo Capital, Llc, and Vestal Point Capital, Lp. InsiderSet ranks institutional holders by their latest reported DRUG position.
What is DRUG institutional ownership?
This page tracks DRUG positions reported by institutional investment managers through SEC Form 13F. BRIGHT MINDS BIOSCIENCES INC (DRUG) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.
How many institutions own DRUG?
InsiderSet currently tracks 103 institutional managers reporting DRUG holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of DRUG shareholders.
How much DRUG stock do institutions own?
Institutional investment managers disclosed approximately $651.60M in DRUG holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.
When was DRUG institutional ownership last updated?
The latest DRUG institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.
Are institutional DRUG holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its DRUG position after the reporting date.
Are institutions buying or selling DRUG?
Institutional buying and selling can be analyzed by comparing DRUG positions across consecutive 13F reporting periods. InsiderSet's DRUG Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View DRUG ownership changes.
How has DRUG institutional ownership changed over time?
InsiderSet tracks DRUG institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.